These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31318843)

  • 21. Measurement of Free Plasma Concentrations of Beta-Lactam Antibiotics: An Applicability Study in Intensive Care Unit Patients.
    Schießer S; Hitzenbichler F; Kees MG; Kratzer A; Lubnow M; Salzberger B; Kees F; Dorn C
    Ther Drug Monit; 2021 Apr; 43(2):264-270. PubMed ID: 33086362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of gatifloxacin alone and in combination with cefepime, meropenem, piperacillin and gentamicin against multidrug-resistant organisms.
    Dawis MA; Isenberg HD; France KA; Jenkins SG
    J Antimicrob Chemother; 2003 May; 51(5):1203-11. PubMed ID: 12697632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of studies on extended versus standard infusion of beta-lactam antibiotics.
    Chen M; Buurma V; Shah M; Fahim G
    Am J Health Syst Pharm; 2019 Sep; 76(18):1383-1394. PubMed ID: 31505562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program.
    Sun HK; Kuti JL; Nicolau DP
    Crit Care Med; 2005 Oct; 33(10):2222-7. PubMed ID: 16215374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of piperacillin, tazobactam, cefepime, meropenem, ciprofloxacin and linezolid in serum using an isotope dilution UHPLC-MS/MS method with semi-automated sample preparation.
    Zander J; Maier B; Suhr A; Zoller M; Frey L; Teupser D; Vogeser M
    Clin Chem Lab Med; 2015 Apr; 53(5):781-91. PubMed ID: 25301676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae.
    Burgess DS; Hall RG
    Diagn Microbiol Infect Dis; 2004 May; 49(1):41-6. PubMed ID: 15135499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of piperacillin, tazobactam, meropenem, ceftazidime, and linezolid in human plasma by liquid chromatography/tandem mass spectrometry.
    Barco S; Bandettini R; Maffia A; Tripodi G; Castagnola E; Cangemi G
    J Chemother; 2015; 27(6):343-7. PubMed ID: 25178412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma and Renal Cortex Meropenem Concentrations in Patients Undergoing Percutaneous Renal Biopsy.
    Sepúlveda RA; Downey P; Soto D; Wong KY; Leung YC; So LY; Andresen M
    Biomed Res Int; 2019; 2019():1368397. PubMed ID: 31828087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug utilization study of two generic antibiotics in a tertiary hospital in Bogotá.
    López JJ; Cortázar Y; Acosta Á; Vargas-Peláez CM; Rossi F
    Biomedica; 2018 Sep; 38(3):398-406. PubMed ID: 30335245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cefepime restriction improves gram-negative overall resistance patterns in neonatal intensive care unit.
    de Araujo OR; da Silva DC; Diegues AR; Arkader R; Cabral EA; Afonso MR; Louzada ME; Albertoni Ade C
    Braz J Infect Dis; 2007 Apr; 11(2):277-80. PubMed ID: 17625777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Covariate determinants of effective dosing regimens for time-dependent beta-lactam antibiotics for critically ill patients.
    Kaska M; Havel E; Selke-Krulichova I; Safranek P; Bezouska J; Martinkova J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Sep; 162(3):219-226. PubMed ID: 29582860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is the effect of obesity on piperacillin and meropenem trough concentrations in critically ill patients?
    Alobaid AS; Brinkmann A; Frey OR; Roehr AC; Luque S; Grau S; Wong G; Abdul-Aziz MH; Roberts MS; Lipman J; Roberts JA
    J Antimicrob Chemother; 2016 Mar; 71(3):696-702. PubMed ID: 26702922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pilot study of oral fluid and plasma meropenem and piperacillin concentrations in the intensive care unit.
    Colman S; Dhaese S; Stove V; De Waele JJ; Verstraete AG
    Clin Chim Acta; 2021 Dec; 523():72-76. PubMed ID: 34508687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. β-Lactam Dosage Regimens in Septic Patients with Augmented Renal Clearance.
    Jacobs A; Taccone FS; Roberts JA; Jacobs F; Cotton F; Wolff F; Creteur J; Vincent JL; Hites M
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein binding of β-lactam antibiotics in critically ill patients: can we successfully predict unbound concentrations?
    Wong G; Briscoe S; Adnan S; McWhinney B; Ungerer J; Lipman J; Roberts JA
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6165-70. PubMed ID: 24080664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of combination therapy with cefepime, piperacillin-tazobactam, or meropenem with ciprofloxacin against multidrug-resistant Pseudomonas aeruginosa strains.
    Erdem I; Kucukercan M; Ceran N
    Chemotherapy; 2003 Dec; 49(6):294-7. PubMed ID: 14671429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HILIC LC-MS/MS method for the quantification of cefepime, imipenem and meropenem.
    Rehm S; Rentsch KM
    J Pharm Biomed Anal; 2020 Jul; 186():113289. PubMed ID: 32428767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of meropenem and piperacillin in critically ill patients with indwelling surgical drains.
    Adnan S; Li JX; Wallis SC; Rudd M; Jarrett P; Paterson DL; Lipman J; Udy AA; Roberts JA
    Int J Antimicrob Agents; 2013 Jul; 42(1):90-3. PubMed ID: 23590897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamic Target Attainment for Cefepime, Meropenem, and Piperacillin-Tazobactam Using a Pharmacokinetic/Pharmacodynamic-Based Dosing Calculator in Critically Ill Patients.
    Heil EL; Nicolau DP; Farkas A; Roberts JA; Thom KA
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29967022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective Comparison of Acute Kidney Injury During Treatment With the Combination of Piperacillin-Tazobactam and Vancomycin Versus the Combination of Cefepime or Meropenem and Vancomycin.
    Peyko V; Smalley S; Cohen H
    J Pharm Pract; 2017 Apr; 30(2):209-213. PubMed ID: 26912532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.